source
- FDA Issues Warning Regarding Risk of Secondary Primary Malignancies With Tazemetostat in Follicular Lymphoma, Epithelioid SarcomaThe FDA issued a warning about the risk of secondary primary malignancies associated with tazemetostat in epithelioid sarcoma and follicular lymphoma.onclive · 3mo ago↗ source
- GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026We spoke with leading voices in GU oncology to see which presentations they are most looking forward to during the 2026 ASCO Annual Meeting.onclive · 3mo ago↗ source
- FDA Finalizes Food Chemical Safety Post-Market Assessment Program, Launches Reassessment of BHT, ADAFDA continues to implement its bold food agenda, with two decisive actions focused on food chemical safety.